SUBSCRIBE
SUBSCRIBE
News   Business

eGene Inc. Revenue Increases 165 Percent In Second Quarter 2006 Compared To Second Quarter 2005

August 14, 2006 | 
1 min read

eGene Inc. (OTCBB:EGEI), a leading bioengineering company and developer of a compact and automated digital genetic analyzer, announced today its results for the second quarter ending June 30, 2006.

Earnings
MORE ON THIS TOPIC
Business
A Conversation with Peter Marks: Insights into GenScript Biotech Forum 2025
January 16, 2025
 · 
1 min read
 · 
Lori Ellis
San Francisco, USA - May 20, 2022: historic Cable Car Powell Hyde Line on turntable at Powell Street terminal at Market Street in downtown San Francisco, California CA, USA.
Pipeline
JPM25 Day 3: AbbVie, Gilead, GSK and Dyne
January 16, 2025
 · 
3 min read
 · 
Tristan Manalac
Business
Dispatches From JPM, Biogen’s Sage Buyout Offer, Pfizer’s Obesity Play, More
January 15, 2025
 · 
1 min read
 · 
Heather McKenzie
Psychedelic Brain
People
Lykos Loses Five Board Directors After FDA Rejection
January 15, 2025
 · 
2 min read
 · 
Tristan Manalac